1. Embosphere微球化疗栓塞中晚期原发性肝癌的安全性、有效性的近 期观察.
- Author
-
虎银宝, 闫东, 李迎春, 蒋小俊, and 夏洪涛
- Abstract
Objective To investigate the safety and efficacy of Embosphere microspheres in the treatment of advanced primary liver cancer.Methods Forty-three patients with primary liver cancer diagnosed by CT or MRI were divided into two groups according to different embolic agents:22 in the Embosphere microsphere group and 21 in the lipiodol + Embosphere microsphere group.The changes of liver and kidney function before and 1~7 days and 1~3 months postoperatively were observed..The difference between the two groups was compared according to the mRECIST criteria,the adverse reaction and complication.Results The changes of liver function in preoperative and postoperative 1~7 days were statistically significant(P<0.05) .Two groups of preoperative and postoperative 1~3 months liver and kidney function changes compared P>0.05 and there was no difference statistically.According to the mRECIST criteria,the effective rate of both groups was statistically significant(X2=4.636, P= 0.0313) .There were no serious adverse reactions and complications after the operation.Conclusions In the chemical therapy,pure embolization is safe and effective to the middle-stage primary liver cancer in Embosphere microsphere group. [ABSTRACT FROM AUTHOR]
- Published
- 2018